MEET NEW DAY DIAGNOSTICS
Pioneering a new era of healthcare by making reliable, early-stage diagnostics accessible and affordable for everyone
Our portfolio of diagnostic solutions is built on a foundation of scientific rigor, clinical expertise, and a deep commitment to patient-centric design. We are creating a connected ecosystem that makes preventive screening more accessible at every step.
Advancing diagnostic science through research, discovery, and clinically grounded innovation.
Designing screening experiences around people, so care feels clearer, simpler, and more personal.
We are not just keeping pace with technology; we are pioneering it. By leveraging state-of-the-art multiomic technologies—such as CorePlex PLUS™—and developing companion diagnostics for pharmaceuticals and biologics.
New Day Diagnostics stands at the intersection of breakthrough technology and compassionate healthcare. By bridging the gap between the lab, the bedside, and the home, we are empowering individuals.
Navroze Mehta
Executive Chairman
Eric Mayer, MS, MBA
Chief Executive Officer
Jay Sitgreaves, EMBA
Chief Operating Officer
Jason Liggett, PhD
Chief Scientific Officer
Suzanne Lee, MPH, PMP
Chief Administrative Officer
Corey DeHaven's
Chief Information Officer
Neeti Dewan, CPA
Chief Financial Officer
Our strategic direction is guided by a distinguished panel of clinical experts who ensure our diagnostic innovations meet the highest standards of medical practice and patient care.
Bergein Overholt, M.D.
Leading expert in biotechnology and molecular diagnostics research.
Herbert A. Fritsche, PhD
Distinguished researcher in clinical chemistry and diagnostic innovation.
Melissa Chiles, MD
Medical Director
Danielle Gibson, MD
Physician Record
Mark Harmon, MD
Medical Affairs Consultant
Our Board of Directors provides the strategic oversight and industry leadership necessary to scale our innovations and deliver sustainable value to the global healthcare ecosystem.
Navroze Mehta
Board Member
Eric Mayer
Board Member
David Allyn
Board Member
Chris Chandler
Board Member
William C. Kouns
Board Member
Autumn Anfang
Board Member
Scott Gucciardi
Board Member
Doug Pinckney
Board Member
OUR LOCATION
Collaborative Excellence
Seamless integration with the UT Medical Center and flagship research campus.
Multidisciplinary Innovation
Tapping into expertise in AI, advanced materials, and human health.
State-of-the-Art Environment
A facility designed to bridge the gap between laboratory discovery and clinical application.
Our state-of-the-art facilities are the engine of our innovation, designed to accelerate the journey from complex biomarker discovery to accessible clinical solutions. By maintaining the highest standards of analytical quality and data integrity, we provide the foundation for the future of diagnostics.
We operate with a commitment to uncompromising quality. Our laboratories are both CLIA-certified and ISO 13485:2016 accredited, ensuring that every test we conduct and every assay we develop meets the most stringent global regulatory requirements.
CLIA-Certified Laboratory operations built around certified quality and patient-ready reporting.
ISO 13485:2016 Design and development processes aligned to international medical device standards.
More than just a testing site, our labs serve as a vertically integrated center for:
Assay Design & Development: Bringing groundbreaking diagnostic concepts to life within a controlled, ISO-compliant environment.
Analytical Validation: Conducting rigorous LoD, LoQ, and interference studies to ensure performance exceeds industry benchmarks.
Clinical Trial Support: Providing high-complexity laboratory services and sample management for pharmaceutical and biotech sponsors.
Explore opportunities to collaborate with New Day Diagnostics — from diagnostic services to investment and strategic partnerships. Reach out using the form below, and a member of our leadership team will connect with you shortly.
